ACE2 and COVID-19: In primary human pulmonary microvascular endothelial cells that naturally express ACE2, S1 subunits instead of intact S protein reduces transendothelial resistance (TER) and barrier function.112 Plasma mediators of severe COVID-19 patients can cause lung endothelial barrier failure.113